Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate

Steven Seto; Alison A Teo; Ryan D Walsh

doi:10.1016/j.jaapos.2019.09.012

Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate

J AAPOS. 2019 Dec;23(6):359-361. doi: 10.1016/j.jaapos.2019.09.012. Epub 2019 Nov 2.

Authors

Steven Seto¹, Alison A Teo¹, Ryan D Walsh²

Affiliations

¹ Department of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin.
² Department of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: rdwalsh@mcw.edu.

PMID: 31683011
DOI: 10.1016/j.jaapos.2019.09.012

Abstract

We report the case of a 2-month-old boy with unilateral pharmacologic mydriasis from inadvertent exposure to glycopyrronium after parental use of glycopyrronium wipes. Clinician familiarity with the potential effects of glycopyrronium exposure may aid in the recognition, diagnosis, and prevention of pharmacologic mydriasis as well as the reduction of costly and unnecessary evaluations.

Published by Elsevier Inc.

Publication types

Case Reports

MeSH terms

Administration, Topical
Cholinergic Antagonists / administration & dosage
Glycopyrrolate / administration & dosage*
Humans
Infant
Male
Mydriasis / chemically induced*
Mydriasis / diagnosis
Mydriasis / physiopathology
Parents*
Pupil / drug effects*

Substances

Cholinergic Antagonists
glycopyrronium tosylate
Glycopyrrolate